US Patent Issued to Washington University on March 31 for "Compounds and methods for treating cancer, viral infections, and allergic conditions" (Missouri Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,123, issued on March 31, was assigned to Washington University (St. Louis).

"Compounds and methods for treating cancer, viral infections, and allergic conditions" was invented by James W. Janetka (St. Louis) and Vishnu Damalanka (St. Louis).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention generally relates to compounds that are useful for inhibiting one or more trypsin-like S1 serine proteases, HGFA, matriptase, hepsin, KLK5 and/or TMPRSS2 as well as cysteine proteases including trypsin-like cysteine proteases (e.g. Cathepsin B). The present invention also relates to various methods of using the inhibitor compounds to treat or pr...